Mr Loganathan S, AVP, Onesource Biopharma

Speaker in this video:
Mr Loganathan S, AVP, Onesource Biopharma
Topic: The strategic shift: Why CDMOs are becoming central to pharma growth
Key Highlights:
[1] Drug delivery combinations are the fastest-growing CDMO segment, with US DDC sales rising 16% annually, driven mainly by GLP-1s and biologics.
[2] OneSource offers end-to-end capability, from cell line development through to drug device assembly and commercial manufacturing.
[3] OneSource combines strong technical acumen with worldwide quality and regulatory expertise across its manufacturing operations.
The post Mr Loganathan S, AVP, Onesource Biopharma appeared first on Express Pharma.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
